Neumora Therapeutics, Inc.'s total assets for Q2 2025 were $223.82M, a decrease of -12.82% from the previous quarter. NMRA total liabilities were $40.95M for the fiscal quarter, a 44.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.